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AbstrACt
Objective Develop and validate an instrument to assess 
family resilience and, more specifically, the family 
dynamics and resources, estimating the adaptation 
flexibility to cancer disease. Cohesion, communication, 
coping style and relational style were considered as critical 
functional areas in the construction of the instrument.
Design Two cross-sectional studies. Study 1: 
identification of factorial structure of the questionnaire in 
two samples with different cancer sites. Study 2: validation 
of the questionnaire in patients with cancer in two different 
phases of their therapeutic pathway.
Participants and setting A total of 213 patients with a 
histologically confirmed non-metastatic breast or prostate 
cancer and 209 caregivers were recruited for the two 
studies from an oncological hospital in Italy.
Outcome measures The Resilience Scale for Adults and 
the Family Resilience (FaRE) Questionnaire, developed by 
the researchers, were administered to all patients and 
caregivers who gave consent.
results In study 1, the 60-item version of the FaRE 
Questionnaire underwent discriminant and construct 
validity, internal consistency and factorial analysis. 
Comparisons between patient and caregiver populations 
showed that patients perceived higher levels of family 
resources (p=0.048) and that patients with prostate 
cancer perceived less social support compared with 
patients with breast cancer (p=0.002). Factor analysis 
demonstrated four domains: communication and cohesion, 
perceived social support, perceived family coping, and 
religiousness and spirituality. In study 2, the validity and 
factorial structure of the final scale, composed of 24 items, 
were confirmed. The Cronbach alpha of all subscales was 
above 82. Normative values for patients with breast cancer 
can provide indications of family resilience levels.
Conclusions Preliminary findings showed acceptable 
psychometric properties for the FaRE Questionnaire to 
evaluate family resilience in oncological patients and their 
caregivers. Further research should test its sensibility to 
change to assess its use as a psychoemotional monitoring 
tool and its validity in other medical contexts.
IntrODuCtIOn
Resilience is a multifaceted concept that 
can be described as the ability to mobilise 
resources and to adapt to challenging or 
adverse situations.1 2 One of the internal 
resources of resilience is coping, which 
consists of a set of modifiable skills that can 
be learnt to deal with a stressful life event.3 
More and more often, resilience is studied 
as a relevant aspect when facing a disease 
such as cancer.4–6 However, the impact of 
disrupting events, such as a cancer diagnosis, 
is not limited only to the individual; rather, 
it influences also their family and social 
network, which can initiate or support posi-
tive adaptation, as well as be overwhelmed by 
the demands of the disease and its treatments. 
According to the family systems theory,7 a 
change or a perturbation occurring to one 
member of the system will affect also the 
other members, which may result in a smooth 
adaptation to a new homeostasis or in difficul-
ties that prevent the readjustment process.7 
This translates into clinically significant levels 
of distress, higher risk of developing psycho-
social problems, high levels of conflict and 
low family cohesion.8 Going beyond the idea 
that families which encounter difficulties are 
‘damaged’ or ‘pathological’,9 resilience may 
represent a pivotal concept to analyse and 
support the family in moving towards a new 
strengths and limitations of this study
 ► Questionnaire development and testing were con-
ducted in two phases in order to assess the validity 
and reliability of the final version of the measure.
 ► This is the first measure of family resilience that 
adopts a systemic approach, considering both the 
patient and the caregiver, in light of increasing evi-
dence on the vital role the caregiver.
 ► Results were controlled for the possible confounding 
sociodemographic variables.
 ► Only two oncological populations were recruited, 
making generalisability to all types of patients with 
tumour limited.
 ► Longitudinal measurements are advised to inves-
tigate test–retest reliability and responsiveness to 
changes in the measure.
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balance and in constructing the meaning of the cancer 
event.10 
A substantial contribution to research in family resil-
ience comes from two main models: the Resiliency Model 
of Family Adjustment and Adaptation11 and the Family 
Resilience Framework,9 both of which have been applied 
to oncological settings. Walsh’s framework was chosen for 
various reasons: first, conceptualisation of family resil-
ience in McCubbin et al’s model is quite rigid; it belongs 
to a first wave of resilience research which believed 
that one has to progress through specific steps in order 
to achieve resilience. In addition to this, due to the large 
number of variables involved in the model, it was possible 
for previous studies to validate only parts of it, never in 
its entirety.12 Differently, Walsh9 13 defines resilience as 
the family’s ability to ‘withstand and rebound from adver-
sity, strengthened and more resourceful’, including the 
capacity to cope and to adapt to the stressor and the 
concept of post-traumatic growth. She considers three 
major dimensions as contributing to the system’s resil-
ience: (1) belief systems, (2) organisational patterns and 
(3) communication processes. Each of these overarching 
constructs is composed of three subprocesses: making 
meaning of adversity, positive outlook, transcendence 
and spirituality, flexibility, connectedness, social and 
economic resources, communication/problem solving, 
clarity, open emotional expression and collaborative 
problem solving. These are considered mutually inter-
active and synergistic as they facilitate and sustain each 
other across systems and over time.13 Walsh also proposed 
an integrative family resilience model for illness-related 
challenges, including cancer14; currently, there is no 
quantitative evidence regarding the framework’s efficacy.
Only three questionnaires have attempted to capture 
the multiple dimensions of Walsh’s9 framework. Sixbey15 
developed the Family Resilience Assessment Scale (FRAS), 
a 66-item measure with responses given on a 4-point 
Likert scale. The statistical considerations and factor 
loadings showed that a nine-construct model of family 
resilience was not supported, and therefore, the number 
of factors was reduced to six15: (1) family communication 
and problem solving, (2) social and economic resources, 
(3) maintaining a positive outlook, (4) family connect-
edness, (5) family spirituality and (6) making meaning 
of adversity. One of the subscales, communication and 
problem solving, is an overarching construct of Walsh’s 
model, which originally contained three subprocesses 
The questionnaire was administered to the general Amer-
ican population without considering an essential aspect 
of resilience, namely, whether an adversity had occurred. 
A second validation study suggested that the FRAS could 
be a reliable and valid measure in a population that was 
not experiencing an adversity.16 This is the major weak-
ness of the measure, which has then been administered 
to families that have experienced difficult diagnoses, 
such as autism spectrum disorder17 and epilepsy,18 where 
disagreement regarding the number of factors of the 
scale is highlighted.18 In addition to this, the measure 
was never administered to multiple members of a family; 
therefore, the perspective of the questionnaire is indi-
vidualistic and is not representative of the family unit as 
a whole. As individual perceptions of which resilience 
resources are activated may vary, it is essential to compare 
the views of different family members.19
The other two measures developed according to Walsh’s 
framework are the Family Resilience Assessment (FRA20) 
and the Walsh Family Resilience Questionnaire (Walsh9). 
The former is composed of 29 items on a 5-point scale 
response and was validated in a sample of women with a 
history of breast cancer. The developers20 warned that the 
items did not always reflect Walsh’s indicators, decided 
to group the items in the three overarching dimensions 
and suggested that socioeconomic resources have little 
value in breast cancer survivors. Lane and Meszaros 
imply that further studies should capture the pluralistic 
view of the family members.20 To date, the FRA has not 
been used in other oncological or more general health 
contexts, suggesting the need for further studies in order 
to consider the instrument a valid measure. In addition 
to this, the recruited sample was small and different 
subgroups were present: survivors who had received diag-
nosis in the past 15 years, others in the past 5 years and 
another group of women undergoing treatment, of which 
half has a stage IV breast cancer diagnosis. Therefore, 
both current and retrospective accounts of resilience 
were collected. Finally, Walsh19 developed her own self-re-
port questionnaire, composed of 33 items that operation-
alise her nine key processes and provide a map of each 
family. While she states that her questionnaire is being 
applied in several international projects, data from these 
studies have not been published yet.
As there is only one measure of family resilience in 
patients with cancer,15 which has an individualistic view 
of resilience and does not capture the systemic processes 
involved, a new measure including Sixbey’s six factors was 
developed. These factors were chosen, compared with 
Lane’s three factors, as, in our opinion, not all salient 
aspects of family resilience in cancer had been consid-
ered and to avoid construct under-representation, one of 
the major threats to construct validity.21 The aim of this 
measure is to investigate family resources and strengths 
during cancer management, taking into account both the 
patient’s and the caregiver’s perspectives.
MAterIAls AnD MethODs
All study phases were presented in a single protocol to 
the local ethics committee, which approved all its parts 
on 11 April 2016. The aim of the first study was to develop 
a questionnaire, the Family Resilience (FaRE) Question-
naire to assess resilience in families affected by cancer. 
Following Messick’s21 guidelines for validating a measure, 
the following stages were conducted: substantive, struc-
tural and external. While substantive and structural steps 
were undertaken in study 1, the external stage was present 
in study 2.
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study 1: item-generation phase and development of the 
questionnaire
For the substantive stage, a first version of the FaRE Ques-
tionnaire was constructed by the authors after a thorough 
revision of scientific literature in the field of resilience and 
cancer and after conducting informal, clinical appoint-
ments with 20 patients with cancer about strategies that 
helped them adjust and cope with the illness. The ques-
tionnaire was then developed and assessed by an expert 
panel composed of psychologists that conduct research 
in the field of resilience. Some minor adjustments to the 
questions were made, and five items were dropped as they 
were considered too similar to other statements. Finally, 
this preliminary version of the FaRE Questionnaire was 
administered to a pilot group of 10 citizens, 10 patients 
with cancer and 10 caregivers comparable to the target 
population in order to evaluate item comprehensibility, 
provide suggestions and indicate which items seemed 
unclear. Six items were reworded to improve under-
standing. The second version of the questionnaire was 
composed of 60 items referring to six aspects: (1) family 
communication and problem solving, (2) social and 
economic resources, (3) maintaining a positive outlook, 
(4) family connectedness, (5) family spirituality and (6) 
ability to make meaning from adversity. Questions were 
on a 7-point Likert scale (from strongly agree to strongly 
disagree).
Item-selection phase
Participants
Couples of patients and caregivers who fitted the inclu-
sion criteria were asked to participate in the current study. 
Participation was proposed to a total of 146 couples, 42 of 
which refused due to little interest in the study or lack 
of time. A total of 105 patients (53 patients with breast 
cancer and 52 patients with prostate cancer) and 105 
caregivers (ie, son/daughter, wife/husband/partner, 
father/mother and sister/brother) were recruited for the 
study at a comprehensive cancer centre in northern Italy. 
Patients were recruited from two outpatient clinics, one 
of the breast cancer division, the second of the urology 
division. In addition to this, patients undergoing onco-
logical treatment were recruited from the radiotherapy 
division and day hospital. If compatible with the research-
er’s availability, consecutive patients who were waiting for 
their appointment were enrolled in the study. Once the 
study’s aims and procedures were illustrated, all partici-
pants gave written informed consent.
Inclusion criteria for patients were the following: (1) 
between 25 and 80 years of age; (2) non-metastatic cancer 
diagnosis of breast or prostate cancer and (3) absence of 
psychiatric, addictive or cognitive disorders that would 
prevent compliance with protocol requirements.
The inclusion criteria for caregivers were (1) over 18 
years old; (2) having a relative with a diagnosis of breast 
or prostate cancer and (3) absence of psychiatric, addic-
tive or cognitive disorders that would prevent compliance 
with protocol requirements.
Due to incomplete answers of one patient, his data were 
not included in the database; therefore, the final sample 
was composed of 104 patients and 105 caregivers.
Materials
The revised version of the FaRE Questionnaire, obtained 
at the end of the pilot study, was composed of 60 items 
and was administered to patients and caregivers partici-
pating in the study.
The Italian version of the Resilience Scale for Adults 
(RSA)22 was chosen to assess the convergent validity of 
the FaRE Questionnaire. The RSA is a 33-item self-re-
port scale for adults that measures six resilience factors: 
perception of self, planned future, social competence, 
structured style, family cohesion and social resources. It 
provides a total mean score, with higher scores indicating 
higher resilience. Four factors measure the individual’s 
characteristics, one factor measures the family environ-
ment and the last factor measures social networks. Cron-
bach alphas for the Italian version ranged from 0.75 to 
0.90 for all subscales and total score with the exception of 
structured style (0.34).
Patient involvement and procedure
The patients in this study were participants. They were 
not involved in thedevelopment of the research question 
or in the recruitment phase. However, patients were asked 
for feedback on the readability of the questionnaire in 
the pilot phase, and their suggestions were incorporated 
in the final version of the FaRE Questionnaire.
Participants were approached by the researcher while 
they were in the waiting hall for the appointment with a 
healthcare professional (oncologist, surgeon or nurse). 
The researcher explained the purposes of the study and 
asked both the patient and the caregiver if they were inter-
ested in participating. If they answered affirmatively, an 
appointment was made after their medical consultation, 
during which further details were given, together with an 
informed consent that was signed by both the researcher 
and the participants. The questionnaires were adminis-
tered on an iPad; for those who did not use electronic 
devices, paper-and-pencil versions of the questionnaires 
were given.
Statistical analyses
All statistical analyses were conducted using SAS V.9.2. 
The first step was an exploratory factor analysis (EFA) 
to reduce the item pool.23 The EFA was conducted using 
maximum likelihood factoring with orthomax rotation. 
Several criteria provided guidelines in selecting the 
number of factors to extract.24 Factors with eigenvalues 
greater than 1 were retained, and an examination of 
scree plots of eigenvalues and total variance explained by 
retained factors helped to determine the total number 
of factors to retain (see figure 1). More generally, in the 
early stages and throughout the entire process, the items 
retained were those with the highest explained variance 
for each factor.
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The Kaiser-Meyer-Olkin (KMO) test for sampling 
adequacy was conducted on the sample to evaluate the 
adequacy of data.25
A Cronbach coefficient alpha was calculated for the 
entire scale and for each individual subscale to assure 
internal consistency and reliability. To further assess 
internal reliability, additional indices were computed: 
average variance extracted (AVE) values and Joreskog rho 
values.26 27
To evaluate the goodness of fit between the models 
and factorial invariance, we used fit indices, including 
the Bentler comparative fit index (CFI), the root mean 
square error of approximation (RMSEA), which indi-
cates the amount of unexplained variance, and the stan-
dardised root mean square residual (SRMR).
Intraclass correlations (ICCs) were computed to 
measure inter-rater reliability.
Median values, SD, and first and third quartiles are 
presented for total and subscale FaRE scores. Values are 
presented also for patients and caregivers separately, 
by age groups, levels of education, marital status and 
number of children, and they are compared by Wilcoxon 
signed-rank tests. We did not expect differences between 
sociodemographic categories, while we expected that 
differences could arise between patients and caregivers, 
as activation of resources can differ, depending on the 
role of the family member in adjusting to the illness.
In order to investigate concordance between patients’ 
and caregivers’ scores, only scores of patients for which 
a corresponding caregiver’s score was available were 
included. Differential scores were computed for each 
factor by subtracting the score of the patient from that 
of the corresponding caregiver. Paired t-tests were calcu-
lated to test the differences.
results
Descriptive statistics
The median age of the population was 60 years old, with 
an IQR from 51 to 66.
Sixty per cent of caregivers were women. Seventy-one per 
cent of caregivers were wife/husband/partner, 14% were 
son/daughter, 11% were sister/brother and the remaining 
4% were mother/father to the patient. The majority of 
the participants was married or in a relationship (83.7% 
and 81% for patients and caregivers, respectively) and had 
children (84.6% and 76.2% for patients and caregivers, 
respectively). Most participants had a high school degree 
(41.3% for patients and 44% for caregivers) or higher 
(33.7% for participants and 29% for caregivers). No socio-
demographic variables were significantly different between 
groups. Further descriptive data can be found in table 1.
Around 83% of patients with breast cancer and 45% 
of patients with prostate cancer were diagnosed with 
stages I and II, and the remaining patients had stages 
III and IV tumours. All patients with breast cancer and 
most patients with prostate cancer had undergone at least 
one type of oncological therapy previously (radiotherapy, 
chemotherapy and/or surgery). One patient with pros-
tate cancer underwent positron emission tomography 
scan for tumour staging several weeks after completing 
the questionnaires, and the test indicated the presence 
of metastases. Further clinical data can be found in the 
online supplementary material.
Factorial analysis
The KMO test scores for sampling adequacy were above 
0.8 (overall KMO=0.92, patient sample KMO=0.9 and 
Table 1 Sociodemographic characteristics of the sample
Total 
(n=209)
Patients 
(n=104)
CG 
(n=105) P values
Age (years) 
  <50, n (%) 43 (20.6) 22 (21.2) 21 (20) 0.84
  ≥50, n (%) 162 (77.5) 80 (76.9) 82 (78.1)
  Missing, n (%) 4 (1.9) 2 (1.9) 2 (1.9)
Gender 
  Male, n (%) 93 (44.5) 51 (49) 42 (40) 0.19
  Female, n (%) 116 (55.5) 53 (51) 63 (60)
Education 
  Elementary–
middle, n (%)
49 (23.4) 23 (22.1) 26 (24.8) 0.76
  High school, 
n (%)
90 (43.1) 43 (41.3) 47 (44.8)
  University, n 
(%)
66 (31.6) 35 (33.7) 31 (29.5)
  Missing, n (%) 4 (1.9) 3 (2.9) 1 (1)
Marital status 
  Single,* n (%) 35 (16.7) 17 (16.3) 18 (17.1) 0.83
  Married, n (%) 172 (82.3) 87 (83.7) 85 (81)
  Missing, n (%) 2 (1) 0 (0) 2 (1.9)
Children 
  None, n (%) 39 (18.7) 16 (15.4) 23 (21.9) 0.36
  1–2, n (%) 133 (63.6) 68 (65.4) 65 (61.9)
  >2, n (%) 35 (16.7) 20 (19.2) 15 (14.3)
  Missing, n (%) 2 (1) 0 (0) 2 (1.9)
*Single: never married or widow or separated.
CG, caregiver.
Figure 1 Eingenvalues and proportion of variance of the 
factors.
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caregiver sample KMO=0.84), indicating that the data 
were suitable for factorial analysis.25
Explained variance was over 10% for four factors; for 
the remaining two factors, the explained variance was 
under 5%, which was considered too low to be retained 
and were therefore excluded. Factor 5 had only two items, 
factor 6 had three items and in both factors, the items were 
unrelated to each other. EFA indicated four factors: one 
factor (factor 5) of the initial version of the questionnaire 
was removed (‘ability to make meaning from adversity’), 
and some items of two factors, namely, ‘family communi-
cation and problem solving’ and ‘family connectedness’, 
were collapsed into a new subscale, communication and 
cohesion (supplementary material). For each factor, the 
items with the highest weights were selected. There are 
eight items for factors communication and cohesion and 
perceived social support, and there are four items for 
perceived family coping, religiousness and spirituality.
A sufficient model fit (Bentler CFI) was defined as 0.90 
or greater, with an RMSEA of 0.06 or less.28 The Bentler 
CFI was 0.94 (χ2=2571.16, df=276, p<0.001), with an 
RMSEA estimate 0.05, indicating an adequate fit between 
the model and the data.
Final version of the questionnaire
The final factors of the FaRE Questionnaire are four 
(see online supplementary material). Communication 
and cohesion (items 1, 4, 7, 10, 13, 16, 19 and 22) refers 
to the family’s openness in communicating about the 
illness and its impact on their daily life. It also involves 
shared problem solving and decision-making, resolution 
of conflict and openness regarding the range of feel-
ings they are experiencing. The second factor, perceived 
social support (items 2, 5, 8, 11, 14, 17, 20 and 23), refers 
to mutual support, reaching out to extended kin and 
community for help with practical and emotional tasks. 
The third factor, perceived family coping (items 3, 9, 
15 and 21), includes the ability to activate coping strat-
egies and to develop inner strength to deal with illness 
management. The concept of bouncing back and the 
ability to rebound from this stressful life event are present 
in this subscale. The last factor, religiousness and spiritu-
ality (items 6, 12, 18 and 24), refers to spiritual values, 
transcendent beliefs and congregational support.
Internal consistency
An alpha of 0.70 is nowadays considered as acceptable 
for a new instrument.29 The alpha computed for each 
of the four subscales exceeded the minimum value for a 
new tool. The Cronbach alphas for each factor were 0.88, 
0.88, 0.82 and 0.86, respectively. AVE values were 0.52, 
0.48, 0.58 and 0.71, and Joreskog rho values were 0.90, 
0.88, 0.84 and 0.91, respectively. As an AVE value of 0.5 
or more indicates good reliability and a rho value of 0.70 
indicates acceptable reliability, it is possible to assume 
adequate internal consistency.26 27
Comparison between patients and caregivers
All FaRE ICC coefficients were between 0.44 and 0.53, 
indicating an overall weak to moderate inter-rater reli-
ability,30 suggesting that there is a variation between 
patients and caregivers in rating the family resilience 
constructs.
Perceived family coping was significantly different 
between patients and caregivers, the former perceiving 
higher levels of family resources (median score 
of patients=6.3, median score of caregivers=6.0; p=0.048). 
A comparison was carried out also within patient–care-
giver dyads, and the difference was not significant for any 
factor (see online supplementary material).
Comparison between populations of patients with cancer
Perceived social support was significantly different 
between patients with breast cancer and patients with 
prostate cancer. The former reported receiving greater 
support from family and friends for their disease 
compared with the latter (p=0.002). Table 2 details the 
results of the non-parametric tests.
Table 2 Non-parametric tests on Family Resilience factors
Factors
Patients (n=104) CG (n=105)
P valuesMedian SD Q1 Q3 Median SD Q1 Q3
Communication and cohesion 6.6 0.9 5.7 7.5 6.5 0.8 5.7 7.3 0.238
Perceived social support 5.9 1.2 4.7 7.0 5.8 1.1 4.6 6.9 0.542
Perceived family coping 6.3 0.8 5.4 7.1 6.0 1.0 5.0 7.0 0.048
Religiousness and Spirituality 4.5 1.8 2.7 6.3 4.8 1.9 2.9 6.6 0.341
Breast (n=53) Prostate (n=51)
Communication and cohesion 6.6 0.7 5.9 7.4 6.8 1.1 5.7 7.8 0.180
Perceived social support 6.3 0.8 5.4 7.1 5.5 1.3 4.2 6.8 0.002
Perceived family coping 6.0 0.9 5.1 6.9 6.5 0.7 5.8 7.2 0.171
Religiousness and Spirituality 4.8 1.8 3.0 6.5 4.3 1.9 2.3 6.2 0.285
P values are from Wilcoxon signed-rank tests. Q1 and Q3 are the first and third quartiles.
CG, c aregiver .
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study 2: validation of the Fare Questionnaire
The second study was designed to validate the facto-
rial structure of the questionnaire in a new sample of 
patients with breast cancer in two different phases of 
their therapeutic pathway: preadmission phase (either 
for day-surgery admission or for ordinary surgery admis-
sion) and treatment phase (surgery, radiation therapy or 
chemotherapy). In addition to this, the external stage of 
validation was conducted by assessing construct validity 
with some of the RSA and FaRE subscales. We expected 
to see positive correlations between (1) RSA and FaRE 
total scores, (2) RSA Family Cohesion Subscale and FaRE 
Communication and Cohesion Subscale, and (3) RSA 
Social Resources and FaRE perceived social support. 
While total scores should correlate as some individual 
resources could reflect in family resilience, the other two 
correlations were expected as they had common under-
pinning psychological constructs. Finally, significant 
correlations were hypothesised between RSA perception 
of self and FaRE family coping, as the RSA factor incor-
porates positive outlook, confidence and self-efficacy, 
aspects that are present in the systemic view of the family 
coping subscale.
Participants
A total of 143 couples were approached to explain the 
study; 34 couples refused due to time constraints between 
appointments or due to little interest in participating. 
Only patients with breast cancer were recruited at this 
time due to easier access to patient waiting rooms, higher 
number of accesses in the hospital and higher compliance.
A total of 109 breast patients from a comprehensive 
cancer centre in northern Italy and 104 family caregivers 
were recruited for the study. Four caregivers were not able 
to come to the consultation on the scheduled day and 
thus could not provide informed consent; their responses 
therefore were not considered for the data analysis. The 
procedure of recruitment was the same as that for the first 
study.
Materials
The final version of the FaRE Questionnaire obtained at 
the end of study 1, which consisted of 24 items, was admin-
istered to patients and caregivers (see online supplemen-
tary material). As in study 1, the RSA scale22 was chosen to 
assess the convergent validity of the FaRE Questionnaire.
Statistical analyses
SAS software V.9.2 was used to conduct all statistical anal-
yses. Confirmative factorial analysis was conducted on the 
final version of the questionnaire. Multigroup factor anal-
ysis was conducted to test for factorial invariance across 
patients and caregivers. Wilcoxon signed-rank tests were 
conducted to evaluate possible differences in clinical 
and sociodemographic characteristics between the two 
samples and differences in factors between study 1 and 
study 2.
In order to assess construct validity of FaRE Ques-
tionnaire, we analysed whether the subscales of the 
questionnaire correlated with the RSA using Spearman 
correlations.
Finally, we tested the model separately in each of the 
group, caregivers and patients, and tested the goodness 
of fit of our four-factor model with a more conservative 
three-factor model to compare differences in practical 
fit indices and to evaluate whether strong factorial invari-
ance, which requires a change in RMSEA of less than 0.015 
or a change in CFI of less than 0.01,28 is supported.
results
Descriptive statistics
The median age of the population was 49, with IQR from 
43 to 56. Thirty-three per cent of the caregivers were 
women. Most participants were married or in a relation-
ship (80% and 74% for patients and caregivers, respec-
tively) and had children (95% and 92% for patients and 
caregivers, respectively). The majority of the participants 
had a high school degree or higher (82% for patients and 
82% for caregivers). More than half of the patients were 
not receiving oncological therapy at the time of recruit-
ment and were diagnosed with stages I and II breast 
cancer. Further descriptive information can be found in 
table 3.
Confirmatory factorial analysis
Weak factorial invariance suggested acceptable measure-
ment invariance (patients, SRMR=0.079; caregivers, 
SRMR=0.080). The Bentler CFI was 0.90 and the RMR 
estimate was 0.07, indicating an adequate model of fit 
between the model and the data (χ2=3139.36, df=276, 
p<0.001). When testing the goodness of fit of our four-
factor model with a more conservative, three-factor 
model, results yielded similar fit indices. The three-factor 
model had a Bentler CFI equal to 0.951 and an RMSEA 
estimate equal to 0.0516 (χ2=2044.46, df=190, p<0.0001), 
while the four-factor model’s Bentler CFI was 0.942 and 
the RMSEA estimate was 0.0513 (χ2=2571.16, df=276, 
p<0.0001).
Difference between the two models in RMSEA scores 
was 0.00003 and in CFI was 0.009, providing evidence for 
strong factorial invariance.31
Construct validity
Total scores of FaRE and RSA were positively correlated 
(ρs=0.43, p<0.0001). Factor communication and cohe-
sion correlated positively with factor family cohesion in 
RSA (ρs=0.56, p<0.0001). Factor perceived social support 
correlated positively with factor social resources (ρs=0.54, 
p<0.0001). Factor perceived family coping correlated posi-
tively with factor structured style (ρs=0.30, p<0.0001) and 
with factor perception of self in RSA (ρs=0.42, p<0.0001).
Differences between study 1 and study 2 samples
Wilcoxon signed-rank tests indicated no differences 
between the median values of factors in the samples in 
study 1 and study 2, both when considering together the 
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patients and the caregivers, as well as when the patients 
and the caregivers were compared separately.
Normative family resilience score
Due to disparity in number between patients with pros-
tate cancer and patients with breast cancer, normative 
data were calculated on the total number of patients 
with breast cancer recruited for the two studies (n=317). 
The mean (5.7) and SD (0.78) for the total FaRE score 
were calculated. As with other clinical measures, scores 
between ±1 SD can be considered in the normal range, 
scores between −1 and −2 SD could indicate lower levels of 
family resilience and scores under 2 SD could be consid-
ered clinically relevant. For the last two ranges of scores, 
referral to support services would be recommended.
DIsCussIOn
The FaRE Questionnaire is designed to measure family 
resilience in oncological settings. Adopting a systemic 
approach, it considers both the patient and the caregiv-
er’s strengths and resources in managing the disease. Our 
initial version of the questionnaire had the same six family 
resilience constructs addressed by Sixbey15; however, a 
six-factor solution was not supported, and it was reduced 
to four factors. Compared with Sixbey’s15 questionnaire, 
the FaRE Questionnaire does not include ‘making 
meaning of adversity’ and ‘positive outlook’; however, 
the latter is addressed in the perceived family coping 
subscale of the FaRE Questionnaire. Sixbey’s connected-
ness construct is incorporated in family communication 
and cohesion. While Lane’s20 family resilience measure 
had highlighted that socioeconomic resources had little 
value to survivors of breast cancer, our measure suggests 
that social resources provide an invaluable support to the 
family coping with cancer and that economic resources 
were unrelated to the social ones. The development of the 
current questionnaire confirms that different resources 
are activated when families face cancer compared with 
other adversities and/or the general population.
An important aspect to keep in mind is the low inter-
rater reliability between patients and caregivers, and this 
is partly explained by the significant differences found 
between some FaRE factors. Patients perceived signifi-
cantly higher levels of family coping and higher levels of 
social support compared with their caregivers; although 
the difference in scores was small, it could be explained 
by the redirection and allocation of shared coping strate-
gies towards the patient rather than towards the caregiver. 
This suggests that it is vital to consider the pluralistic view 
of family members as they are actively involved in cancer 
management. Further research should try and disen-
tangle whether lower support and family coping scores 
of caregivers are of clinical significance, for instance, by 
assessing the association with mood profiles.
Recruitment of participants from eight different 
regions of Italy and the combination of cognitive inter-
views and expert review, which allowed us to determine 
the relevance of the items, are some of the strengths of 
the study. Another strength of the developed measure 
is its systemic view, which allows use in caregiver popula-
tions, for whom there are only a few questionnaires avail-
able, possibly because attention towards their challenges 
and needs has increased only in the last few years.32 33
This said, there were some limitations in the develop-
ment of the current questionnaire. The sample size of 
the first study is relatively small, considering the number 
of items of the first version of the FaRE Questionnaire; 
a larger sample could have highlighted missing aspects. 
Table 3 Descriptive statistics of the second sample
Overall 
(n=213)
Patients 
(n=109)
Caregivers 
(n=104)
Age 
  <50, n (%) 116 (54) 109 (51) 104 (49)
  ≥50, n (%) 97 (46) 60 (55) 56 (54)
Children 
  0, n (%) 47 (22) 49 (45) 48 (46)
  1–2, n (%) 153 (72) 22 (20) 25 (24)
  >3, n (%) 13 (6) 82 (75) 71 (68)
Marital status 
  Single,* n (%) 44 (21) 20 (18) 24 (23)
  Married, n (%) 164 (77) 87 (80) 77 (74)
  Missing, n (%) 5 (2) 2 (2) 3 (3)
Educational level 
  Elementary–middle 
school, n (%)
38 (18) 20 (18) 18 (17)
  High school, n (%) 92 (43) 41 (38) 51 (49)
  University, n (%) 82 (38) 48 (44) 34 (33)
  Missing, n (%) 1 (0) 0 (0) 1 (1)
Stage 
  0, n (%) 11 (10.1)
  I, n (%) 52 (47.7)
  II, n (%) 25 (22.9)
  III, n (%) 20 (18.8)
Previous therapy 
  Surgery, n (%) 42 (38.5)
  Chemotherapy, n (%) 19 (17.4)
  Hormone therapy, n 
(%)
2 (1.8)
  No therapy, n (%) 46 (42.2)
Ongoing therapy 
  Chemotherapy, n (%) 16 (14.7)
  Hormone therapy, n 
(%)
13 (11.9)
  Radiotherapy, n (%) 10 (9.2)
  No therapy, n (%) 70 (64.2)
*Single: never married or widow or separated.
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Convergent and discriminant validity examining similari-
ties and differences between the FaRE Questionnaire and 
other family resilience tools would strengthen the rigour 
of the questionnaire. In addition to this, the cut-off points 
of the total FaRE scores need validating in future studies 
in order to use them as screening for referral. In addition 
to this, it is important to evaluate whether the religious-
ness–spirituality subscale should be included in the total 
score of family resilience and whether it plays a key role 
in promoting resilience levels. To ensure generalisability 
of the results, a larger sample with diverse tumour diag-
nosis should be recruited, as our sample was composed 
of only gender-related tumours with a relatively high 
life expectancy; in addition to this, patients with other 
chronic and acute illnesses should be sampled to evaluate 
whether important family resilience aspects in disease 
management have been dropped. This instrument can 
be a useful tool to assess patients at baseline and for 
continued follow-up; for this reason, test–retest reliability 
and responsiveness to change should be conducted.
Preliminary evidence shows that the FaRE Ques-
tionnaire is a reliable and valid systemic measure of 
family resilience in oncological settings. The tool was 
designed to be implemented in a web platform as a 
part of the works of an European project, which aimed 
at promoting empowerment and self-management in 
patients with cancer.34–36 As increasing attention is being 
paid to family resilience and its protective role in illness 
trajectories, once further validations are conducted, it 
can serve as a useful screening tool to identify patients 
and carers with few resources to deal with cancer-related 
issues. Family resilience screening would allow targeted 
interventions on development and promotion of specific 
strategies and resources that can help the family deal with 
the illness.
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